Use of the new superRCA mutation assay for molecular MRD monitoring using flow cytometry in pediatric AML
AWARD WINNING PRESENTATION at ESCCA 2023: MRD on flow cytometer using superRCA
HEM-51: NRAS, WT1, NPM1 and IDH mutation detection for molecular MRD-assessment using Flow Cytometry in pediatric AML
Ultra-sensitive molecular MRD by flow cytometry using superRCA mutation assay for NPM1 positive AML patients